Zynerba Pharmaceuticals announces proposed public offering of common stock
Zynerba Pharmaceuticals announced it intends to offer and sell shares of its common stock in an underwritten public offering. Zynerba intends to grant underwriters a 30-day option to purchase up to an additional 15% of the shares of its common stock offered in the public offering. July 19, 2018